Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TAP2D

K-Number: K252649 · 2026-02-02

Decision Date2026-02-02
Product CodeIZF
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

TAP2D is a medical device manufactured by Nano-X Imaging , Ltd.. It received FDA 510(k) clearance on 2026-02-02 under approval number K252649. The device is classified under product code IZF. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TAP2D?

TAP2D is a medical device that received FDA 510(k) clearance on 2026-02-02. It is manufactured by Nano-X Imaging , Ltd.. The 510(k) number is K252649.

When was TAP2D approved by the FDA?

TAP2D received FDA 510(k) clearance on 2026-02-02, under approval number K252649.

What company makes TAP2D?

TAP2D is manufactured by Nano-X Imaging , Ltd..

What is the FDA product code for TAP2D?

The FDA product code for TAP2D is IZF.

Other Devices by Nano-X Imaging , Ltd.

Related Devices (Code: IZF)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.